ResMed : Virtual Investor Day

ResMed Investor Day

September 8, 2021

Forward Looking Statements

Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated.

This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial measures in this presentation, which include non-GAAP Income from Operations, non-GAAP Net Income, and non-GAAP Diluted Earnings per Share, should be considered in addition to, but not as substitutes for, the information prepared in accordance with GAAP. For reconciliations of the non-GAAP financial measures to the most comparable GAAP measures, please refer to the earnings release associated with the relevant reporting period, which can be found on the investor relations section of our corporate website (investor.resmed.com).

In addition to historical information, this presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

These forward-looking statements are based on ResMed's current expectations of future revenue or earnings, new product development, new product launches, new markets for its products, integration of acquisitions, leveraging of strategic investments, litigation, and tax outlook. Forward-looking statements can generally be identified by terminology such as "may", "will", "should", "expects", "intends", "plans", "anticipates", "believes", "estimates", "predicts", "potential", or "continue", or variations of these terms, or the negative of these terms or other comparable terminology.

ResMed's expectations, beliefs, and forecasts are expressed in good faith and are believed to have a reasonable basis, but actual results could differ materially from

those stated or implied by these forward-looking statements. ResMed assumes no obligation to update the forward-looking information in this presentation, whether as a result of new information, future events, or otherwise. For further discussion of the various factors that could impact actual events or results, please review the "Risk Factors" identified in ResMed's quarterly and annual reports filed with the SEC. All forward-looking statements included in this presentation should be considered in the context of these risks. Investors and prospective investors are cautioned not to unduly rely on our forward-looking statements.

© 2021 ResMed | 2021 Investor Day - Sept 8, 2021

2

Today's Agenda

1:30 PM	Welcome and Opening Remarks
	Amy Wakeham
	VP, IR and Corporate Communications
	Transforming Care as the World-Leading
	Digital Health Company
	Mick Farrell
	Chief Executive Officer
	Global Corporate Strategy
	Hemanth Reddy
	Chief Strategy Officer
	Pioneering the Future of Sleep
	Jim Hollingshead
	President, Sleep and Respiratory Care Business
	Software as a Service (SaaS)
	Bobby Ghoshal
	President, SaaS; Chief Technology Officer
2:40 PM	Q&A Session

3:10 PM	Break
3:25 PM	Leadership in Digital Health Technology
	Bobby Ghoshal
	President, SaaS; Chief Technology Officer
	Driving Operational Excellence
	Rob Douglas
	President and Chief Operating Officer
	Financial Strategy
	Brett Sandercock
	Chief Financial Officer
	Closing Remarks
	Mick Farrell
	Chief Executive Officer
4:15 PM	Q&A Session
5:00 PM	Event End

© 2021 ResMed | 2021 Investor Day - Sept 8, 2021

3

Transforming Care as the

World-Leading Digital Health Company

Mick Farrell | Chief Executive Officer

Key messages

1 Positioned to continue winning in large, underserved respiratory medical markets with a patient-centric approach, unique ResMedian culture, and 30+ years of cutting-edge innovation

2	Leading the market in digital health - continue to disrupt and reinvent the medical device
industry with cloud-connected devices, market-leading software solutions, and innovative analytics

3	Transforming out-of-hospital care at scale leveraging integrated healthcare models
and partnerships to provide top-quality care at lower-acuity and people-friendly environments

4 Executing ResMed 2025 strategy to improve 250 million lives in out-of-hospital care by helping people breathe better, sleep better, and live better lives: all driving stakeholder value

© 2021 ResMed | 2021 Investor Day - Sept 8, 2021

5